These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 4798236)

  • 21. Establishment of a national network of validated and qualified laboratories for neutralizing anti-vaccinia antibodies titration.
    Poirier B; Leparc-Goffart I; Crance JM; Fleury H; Garin D; Gut JP; Tissier MH; Fuchs F
    Biologicals; 2005 Dec; 33(4):277-82. PubMed ID: 16181788
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reversed passive haemagglutination-inhibition method for the estimation of antivaccinia antibodies.
    Nyerges G
    Immunology; 1969 Sep; 17(3):333-7. PubMed ID: 5352004
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neutralizing and protective antibodies directed against vaccinia virus envelope antigens.
    Galmiche MC; Goenaga J; Wittek R; Rindisbacher L
    Virology; 1999 Feb; 254(1):71-80. PubMed ID: 9927575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Standardization of a neutralizing anti-vaccinia antibodies titration method: an essential step for titration of vaccinia immunoglobulins and smallpox vaccines evaluation.
    Leparc-Goffart I; Poirier B; Garin D; Tissier MH; Fuchs F; Crance JM
    J Clin Virol; 2005 Jan; 32(1):47-52. PubMed ID: 15572006
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Viral antibody production in animals exposed to a space cabin environment. SAM-TR-66-82.
    Giron DJ; Schmidt JP
    Tech Rep SAM-TR; 1966 Sep; ():1-4. PubMed ID: 4380893
    [No Abstract]   [Full Text] [Related]  

  • 26. [Irreversible inactivation of vaccinia and poliomyelitis viruses with homologous antibodies in the presence of cofactor].
    Shuratov IKh; Iabrov AA; Smorodintsev AA
    Vopr Virusol; 1968; 13(3):354-9. PubMed ID: 4302363
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparison of humoral immunity and induction of proliferating T lymphocytes in vaccinia virus-infected rabbits and rhesus macaques.
    Schäffner JW; Dittmer U; Otteken A; Coulibaly C; Bodemer W; Voss G; Hunsmann G
    Am J Vet Res; 1994 Sep; 55(9):1250-5. PubMed ID: 7802392
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Neutralization of bovine papillomatosis virus].
    Vardapetian SS
    Arch Exp Veterinarmed; 1973; 27(4):571-2. PubMed ID: 4362367
    [No Abstract]   [Full Text] [Related]  

  • 29. Antibodies to the A27 protein of vaccinia virus neutralize and protect against infection but represent a minor component of Dryvax vaccine--induced immunity.
    He Y; Manischewitz J; Meseda CA; Merchlinsky M; Vassell RA; Sirota L; Berkower I; Golding H; Weiss CD
    J Infect Dis; 2007 Oct; 196(7):1026-32. PubMed ID: 17763325
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clonal vaccinia virus grown in cell culture as a new smallpox vaccine.
    Weltzin R; Liu J; Pugachev KV; Myers GA; Coughlin B; Blum PS; Nichols R; Johnson C; Cruz J; Kennedy JS; Ennis FA; Monath TP
    Nat Med; 2003 Sep; 9(9):1125-30. PubMed ID: 12925845
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibody in tears following intranasal vaccination with inactivated virus. 3. Role of tear and serum antibody in experimental vaccinia conjunctivitis.
    Knopf HL; Blacklow NR; Glassman MI; Cline WL; Wong VG
    Invest Ophthalmol; 1971 Oct; 10(10):760-9. PubMed ID: 4941860
    [No Abstract]   [Full Text] [Related]  

  • 32. Accuracy and repeatability of a micro plaque reduction neutralization test for vaccinia antibodies.
    Borges MB; Kato SE; Damaso CR; Moussatché N; da Silva Freire M; Lambert Passos SR; do Nascimento JP
    Biologicals; 2008 Mar; 36(2):105-10. PubMed ID: 17892944
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiserum neutralization of bacteriophage Q beta: a mathematical analysis.
    Hale EM; Hirata AA; Brusenback RA; Overby LR
    J Immunol; 1969 Jan; 102(1):206-14. PubMed ID: 5812757
    [No Abstract]   [Full Text] [Related]  

  • 34. Studies on the non-neutralizable fraction of vaccinia virus.
    Majer M; Link F
    Clin Exp Immunol; 1970 Aug; 7(2):283-91. PubMed ID: 5312264
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Studies on the neutralization of Japanese encephalitis virus. I. Application of kinetic neutralization to the measurement of the neutralizing potency of antiserum.
    Ozaki Y; Tabeyi K
    J Immunol; 1967 Jun; 98(6):1218-23. PubMed ID: 6026747
    [No Abstract]   [Full Text] [Related]  

  • 36. Zoonotic vaccinia virus infection in Brazil: clinical description and implications for health professionals.
    de Souza Trindade G; Drumond BP; Guedes MI; Leite JA; Mota BE; Campos MA; da Fonseca FG; Nogueira ML; Lobato ZI; Bonjardim CA; Ferreira PC; Kroon EG
    J Clin Microbiol; 2007 Apr; 45(4):1370-2. PubMed ID: 17287326
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The influence of normal guinea pig serum on the adenovirus neutralizing activity of immune rabbit sera.
    Svartz-Malmberg G
    Acta Pathol Microbiol Scand; 1969; 75(3):499-507. PubMed ID: 5801665
    [No Abstract]   [Full Text] [Related]  

  • 38. [Relation between antibody formation and immunity against cutaneous vaccinia virus infection in hens].
    Andrzejewski J; Bogunowicz A; Zajac I
    Zentralbl Bakteriol Orig; 1968; 207(3):419-21. PubMed ID: 5745681
    [No Abstract]   [Full Text] [Related]  

  • 39. [Passive hemagglutination test used as method for detection of antibodies in vaccinia].
    Stefănesco V; Mihăilesco R; Grobnico M
    Arch Roum Pathol Exp Microbiol; 1965 Sep; 24(3):771-8. PubMed ID: 5877882
    [No Abstract]   [Full Text] [Related]  

  • 40. Synergistic neutralizing activities of antibodies to outer membrane proteins of the two infectious forms of vaccinia virus in the presence of complement.
    Lustig S; Fogg C; Whitbeck JC; Moss B
    Virology; 2004 Oct; 328(1):30-5. PubMed ID: 15380355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.